Modra Murovska

Modra Murovska, MD, PhD, (b. 1949) is a researcher in virology, medical microbiology, and molecular biology; the Director of A. Kirchenstein Institute of Microbiology and Virology, Riga Stradins University, Riga, Latvia; and an Associate Professor at Riga Stradins University, Riga, Latvia. She is a member of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME).

She is one of the authors of the 2011 case definition, International Consensus Criteria.

In 2009-2012, Dr. Murovska was assigned as Principle Investigator for the Latvian Council of Science in the investigation of etiopathogenesis of chronic fatigue syndrome, post-infection and unspecified origin encephalopathy and elaboration of diagnostic criterions.

Dr. Murovska chairs the Management Committee of the COST Action CA15111/EUROMENE and was the impetus to the program being started.

Education

 * 1972, MD, Riga Medical Institute /Medical Academy of Latvia/ (Faculty of Pediatrics)
 * 1978, Dr.med. (Candidate of Science in former USSR system, Ph.D. in Western countries), Cancer Research Centre, USSR Academy of Medical Sciences, Moscow, Russia

Studies

 * 2016, Occurrence, phase and status of human parvovirus B19 infection in patients with myalgic encephalomyelitis/chronic fatigue syndrome "Conclusions: Results demonstrate finding of human parvovirus B19 persistent infection in active phase significantly more frequent and with higher B19 load among patients with ME/CFS than apparently healthy individuals indicating on implication of B19 infection in pathogenesis of ME/CFS. Therefore markers of active B19 infection could be used as one of biomarkers in ME/CFS diagnostics. Association of persistent B19 infection in active phase with part of typical ME/CFS clinical symptoms shows possible B19 involvement in disease development and reactivation of B19 may be a risk factor for ME/CFS. B19 infection statuses and onset of symptoms allow suggesting the feasible role of B19 infection as a trigger factor for ME/CFS. /
 * 2012, Association of active human herpesvirus-6, -7 and parvovirus B19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
 * 2006, Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome.

Online Presence

 * Pubmed for Modra Murovska
 * Latvian Scientists webpage